Indefinite Delivery Contract HHSF223201510009I

The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery/indefinite quantity multiple award contract to Research Triangle Institute to provide tobacco analysis and engineering laboratory services in support of FDA regulation of tobacco products. Task orders issued against the contract include research and analysis of nicotine salts' impact on leaching metals into e-liquids at locations in Maryland and North Carolina valued at over $45...

This indefinite delivery contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Battelle Memorial Institute, a non-profit organization and manufacturer of goods. The $10 million master IDIQ contract, titled "Tobacco Products Pharmacology Study", is focused on regulatory and scientific efforts related to tobacco products under the FDA's purview. The contract has resulted in several firm fixed-price delivery orders to Battelle, valued at...

The Department of Health and Human Services Food and Drug Administration awarded a single award Indefinite Delivery Indefinite Quantity contract to Labstat International Inc. to provide tobacco laboratory analysis and engineering services. The contract has a potential value of $45 million over five one-year ordering periods. Three firm fixed price delivery orders have been awarded against the contract to date, including for new smoking regimen services generating and quantitating tobacco smoke...

This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to the non-profit Research Triangle Institute (RTI) International. The contract, valued up to $2,500,000, is for engineering analysis laboratory services to support the FDA's regulation of electronic cigarettes and other newly deemed tobacco products. The contract includes two firm fixed-price delivery orders issued to date. The first...

The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Lovelace Biomedical Research Institute with a potential value of $25 million. To date, two firm fixed price delivery orders have been awarded against the contract. Task Order 1, valued at $3.8 million, tasks Lovelace Biomedical Research Institute to determine if reductions in biomarkers of exposure and potential harm are proportional to reductions in cigarette smoking...

The U.S. Food and Drug Administration (FDA) awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract, valued at $5 million, to Labstat International Inc., a Canadian for-profit limited liability company, to provide tobacco analysis laboratory services over a 5-year period. This IDIQ contract allows the FDA to issue multiple firm fixed-price delivery orders for chemical, physical, and microbiological testing of tobacco, e-cigarette, cannabis, and CBD products in support of...

The U.S. Food and Drug Administration (FDA), a civilian agency, awarded a $60 million single-award Indefinite Delivery Contract to Research Triangle Institute (RTI International), a non-profit research organization, for the evaluation of the FDA's Center for Tobacco Products' (CTP) public health education campaigns and communication programs. This contract, which does not have a set-aside designation, has an ultimate completion date of August 29, 2026. Under this IDC, RTI has been awarded...

This is a multiple award indefinite delivery contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to conduct safety evaluation and toxicology studies to support drug development. The $48.6 million contract has a 6-year ordering period from June 2024 to June 2030. The contractor, IIT Research Institute (IITRI), a non-profit research organization, will perform in vitro and in vivo exploratory and...

This federal indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to the non-profit IIT Research Institute (IITRI). The $19 million PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) IDIQ contract vehicle enables NCI to efficiently access IITRI's preclinical research capabilities on an as-needed basis to support the development of cancer prevention therapies. Task orders issued under this...

The key products and services being delivered under this federal contract IDV award from the National Cancer Institute (NCI) are preclinical toxicology studies on small molecule drug candidates for cancer and other indications. The prime contractor, IIT Research Institute (IITRI), a division of the Illinois Institute of Technology, will conduct non-GLP and GLP toxicology assessments in mice and dogs to support Investigational New Drug (IND) applications. IITRI holds several significant IDIQ...